DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "13th Annual Report and Survey Biopharmaceutical Manufacturing Capacity and Production" report to their offering.
This report's 492 pages of data-rich analysis will help improve your decision-making in biomanufacturing operations, with in-depth analysis of capacity, production trends, benchmarks, and much more.
Coverage:
- Biosimilars pipeline in development
- In-depth analysis of key data, capacity, production trends, and benchmarks
- Budget trends and impact of current economic environment
- Expression system advances
- Downstream purification problems and issues
- Current and projected industry bottlenecks
- Capacity utilization and current production levels
- How capacity bottlenecks are being resolved
- Production trends and implications for industry
- Outsourcing trends
- International offshoring through 2021
- Range of titres, growth
- Disposables: Spending growth; downstream uses; L&E's; reasons for increasing/ restricting; budget increases; vendor satisfaction
- Disposables: Compare innovators vs CMOs & US vs Europe
- Batch failure rates & trends
- Selecting a CMO Problems & solutions
- Quality management & PAT implementation
- Hiring and employment growth
- Supplier growth rates
Key Topics Covered:
1: Introduction And Discussion
2: Overview of Critical Issues in Bioprocessing
3: Emerging Issues in Biopharmaceutical Manufacturing
4. Capacity Utilization Trends
5: Current and Future Capacity Constraints
6: Future Capacity Expansions
7: Outsourcing Trends in Biopharmaceutical Manufacturing
8: Disposables and Single-Use Systems in Biopharmaceutical Manufacturing
9: Downstream Purification
10: Quality Issues, Batch Failures, and PAT in Biopharmaceutical
11: Hiring, Employment Growth, and Training in Biopharmaceutical Manufacturing
12: Fill and Finish
13: Suppliers to Biopharmaceutical Manufacturing and Life Sciences
For more information about this report visit http://www.researchandmarkets.com/research/jnqs62/13th_annual
Related Topics: Biopharmaceuticals
